AwardedArchived
6505--Abiraterone Tablets
Awarded tounder 36E79725D0020 (source: SAM.gov award notice)• $20.3M
Overview
- Posted
- April 17, 2025
- Notice type
- Award Notice
Notice details
- Office
- NAC PHARMACEUTICALS (36E797)
- Last updated
- Nov 14, 2026
- First published
- Last updated on SAM.gov
- Award date
- Apr 17, 2025
- Award amount (SAM.gov award notice)
- $20.3M
Identifiers
- Solicitation number
- 36E79725R0005
- Notice ID
- 34a2fe760aef4e1ea09b16df9867278c
- Award number (PIID)
- 36E79725D0020
Description
Abiraterone Tablets RFP 36E79725R0005.
Award Overview
Award Number
36E79725D0020
Award Amount (SAM.gov award notice)
$20.3M
Award Date
Apr 17, 2025
Awardee
Awardee UEI
SFPGXE6XPS93
Awardee CAGE Code
4QGW8
Line Item Number
1
Original Solicitation
Notice ID: 34a2fe760aef4e1ea09b16df9867278c
Posted Date: Apr 17, 2025
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Nov 13, 2026
- —Signed Nov 12, 2026
- —Signed Nov 12, 2026
- —Signed Nov 10, 2026
- —Signed Nov 6, 2026
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
36E79725D0020_1.docx
13 KBAdded in Award Notice version 3Posted
Lifecycle
- 3Version 3Award NoticeArchivedCurrent
6505--Abiraterone Tablets
Other notices for this solicitation
- Pre-SolicitationNov 6, 2024
6505--Abiraterone Tablets
- 2×
- SolicitationRelated noticeJan 7, 2025
6505--Abiraterone Tablets
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79725R0005
Archive Date
Jun 16, 2025